Atlas Trials

Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine

Clinical trial NCT06550609 · RECRUITING

Trial details

NCT number
NCT06550609
Sponsor
Fundacion Nacional de Dermatologia
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Mucosal Leishmaniasis
Start date
2025-02-04
Primary completion
2027-11-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.